跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GD-11
首页
药物
GD-11
GD-11
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
一种超小尺寸CeO2-Gd@BSA-cRGD靶向纳米粒子及其绿色制备方法
申请人: 哈尔滨医科大学
优先权: 2024
CN
MODIFIED MRNA VACCINES ENCODING HERPES SIMPLEX VIRUS GLYCOPROTEINS AND USES THEREOF
申请人: UNIV PENNSYLVANIA
优先权: 2017
EP
2 件公开
11-deoxidized biogastrone acid-3-0-succinic acid half-ester rare earth salt and synthesis thereof
申请人: NANJING UNIVERSITY OF TECHNOLOGY
优先权: 2009
CN
Rare-earth-based fluorine cluster for magnetic resonance imaging and cell imaging as well as preparation method and application of rare-earth-based fluorine cluster
申请人: FIRST AFFILIATED HOSPITAL MEDICAL COLLEGE XIAN JIAOTONG UNIV
优先权: 2026
CN
Compounds for diagnosing and/or monitoring fibrosis
申请人: ANTAROS DETRACKER INC
优先权: 2020
CN
药物
反馈